Glucagon receptor antagonist compounds are disclosed. The compounds are useful for treating type 2 diabetes and related conditions. Pharmaceutical compositions and methods of treatment are also included.
本文披露了胰高血糖素受体
拮抗剂化合物。这些化合物对于治疗2型糖尿病及相关疾病非常有用。此外,还包括药物组合物和治疗方法。